Combination Therapy for Alzheimer’s Disease
Inventor
Prof Ralph Martin, Centre of Excellence for Alzheimer’s Disease Research and Care.
Applications
Pharmaceutical Industry.
IP status
Provisional Patent Filed. IP owned jointly by ECU and Lawley Pharmaceuticals.
Current status
Combinatory effects of testosterone, DHA and Vitamin E.
In collaboration with Lawley Pharmaceutical Ltd researchers have found that testosterone replacement therapy lowers the levels of the Aβ in an animal model and in a human pilot study.